Olema Pharmaceuticals, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Sale | 200 | $17.61 | $3,522 | 561,270 | Nov 8, 2023 |
| Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Sale | 541 | $17.51 | $9,473 | 561,470 | Nov 1, 2023 |
| Harmon Cyrus | — | Sale | 5,000 | $15.64 | $78,200 | 943,714 | Oct 31, 2023 |
| Harmon Cyrus | — | Sale | 25,000 | $12.41 | $310,250 | 973,714 | Sep 29, 2023 |
| Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Sale | 20,000 | $12.67 | $253,400 | 572,011 | Sep 19, 2023 |
| Biotechnology Value Trading Fund OS LP | — | Purchase | 677,853 | $9.84 | $6,670,074 | 3,584,512 | Sep 12, 2023 |
| Harmon Cyrus | — | Sale | 10,000 | $11.62 | $116,200 | 998,714 | Aug 31, 2023 |
| Harmon Cyrus | — | Sale | 15,000 | $10.14 | $152,100 | 1,023,714 | Aug 16, 2023 |
| Harmon Cyrus | — | Sale | 15,000 | $10.14 | $152,100 | 1,023,714 | Aug 16, 2023 |
| Harmon Cyrus | — | Sale | 10,000 | $6.30 | $63,000 | 1,038,714 | Jun 8, 2023 |
| Harmon Cyrus | — | Sale | 5,000 | $6.30 | $31,500 | 1,048,714 | Jun 5, 2023 |
| Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | Purchase | 10,000 | — | — | 396,197 | Apr 6, 2023 |
| Bohen Sean | PRESIDENT AND CEO | Purchase | 20,000 | — | — | 74,279 | Sep 21, 2022 |
| Bohen Sean | PRESIDENT AND CEO | Award / Grant | 20,000 | — | — | 74,279 | Sep 21, 2022 |
| Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | Purchase | 20,000 | — | — | 381,197 | Sep 2, 2022 |
| Biotechnology Value Trading Fund OS LP | — | Purchase | 41,417 | $4.03 | $166,911 | 2,906,659 | Jun 10, 2022 |
| Horn Kinney | CHIEF BUSINESS OFFICER | Sale | 5,253 | $4.75 | $24,952 | 2,458 | Mar 10, 2022 |
| Horn Kinney | CHIEF BUSINESS OFFICER | Disposition | 5,251 | — | — | 2,458 | Feb 10, 2022 |
| Horn Kinney | CHIEF BUSINESS OFFICER | Sale | 5,251 | $6.85 | $35,969 | 2,458 | Jan 10, 2022 |
| Horn Kinney | CHIEF BUSINESS OFFICER | Sale | 5,251 | $10.39 | $54,558 | 2,458 | Dec 10, 2021 |
| Myles David C. | CHIEF DEVELOPMENT OFFICER | Sale | 10,000 | $10.30 | $103,000 | 582,901 | Dec 10, 2021 |
| BIOTECHNOLOGY VALUE FUND L P | — | Purchase | 35,268 | $9.39 | $331,167 | 471,350 | Nov 30, 2021 |
| Harmon Cyrus | CHIEF TECHNOLOGY OFFICER | Sale | 400 | $24.76 | $9,904 | 1,051,146 | Nov 29, 2021 |
| Horn Kinney | CHIEF BUSINESS OFFICER | Option Exercise | 22,417 | $19.00 | $425,923 | 29,458 | Nov 10, 2021 |
| Harmon Cyrus | CHIEF TECHNOLOGY OFFICER | Sale | 4,555 | $28.20 | $128,451 | 1,051,546 | Oct 19, 2021 |
| Bohen Sean | PRESIDENT AND CEO | Sale | 351 | $31.17 | $10,941 | 52,514 | Oct 14, 2021 |
| Horn Kinney | CHIEF BUSINESS OFFICER | Sale | 2,105 | $27.47 | $57,824 | 4,936 | Oct 11, 2021 |
| Bohen Sean | PRESIDENT AND CEO | Option Exercise | 1,085 | $4.82 | $5,230 | 53,599 | Sep 27, 2021 |
| Harmon Cyrus | CHIEF TECHNOLOGY OFFICER | Sale | 12,000 | $26.30 | $315,600 | 1,063,546 | Sep 20, 2021 |
| Horn Kinney | CHIEF BUSINESS OFFICER | Option Exercise | 5,251 | $2.06 | $10,817 | 7,041 | Sep 10, 2021 |
| Bohen Sean | PRESIDENT AND CEO | Option Exercise | 2,631 | $4.82 | $12,681 | 56,905 | Sep 7, 2021 |
| Bohen Sean | PRESIDENT AND CEO | Sale | 871 | $30.05 | $26,174 | 54,274 | Sep 1, 2021 |
| Harmon Cyrus | CHIEF TECHNOLOGY OFFICER | Sale | 12,000 | $24.97 | $299,640 | 1,075,546 | Aug 19, 2021 |
| Horn Kinney | CHIEF BUSINESS OFFICER | Sale | 5,191 | $25.70 | $133,409 | 1,850 | Aug 10, 2021 |
| Harmon Cyrus | CHIEF TECHNOLOGY OFFICER | Sale | 4,123 | $25.63 | $105,672 | 1,087,546 | Jul 19, 2021 |
| Horn Kinney | CHIEF BUSINESS OFFICER | Sale | 3,859 | $26.33 | $101,607 | 3,182 | Jul 12, 2021 |
| Harmon Cyrus | CHIEF TECHNOLOGY OFFICER | Sale | 1,990 | $25.59 | $50,924 | 1,100,146 | Jun 18, 2021 |
| Horn Kinney | CHIEF BUSINESS OFFICER | Sale | 2,787 | $29.97 | $83,526 | 1,790 | Jun 10, 2021 |
| Horn Kinney | CHIEF BUSINESS OFFICER | Sale | 49,142 | $24.03 | $1,180,882 | 10,411 | May 18, 2021 |
| BVF Partners OS Ltd. | — | Other | 99,556 | — | — | 99,556 | Mar 31, 2021 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | — | C | 1,273,420 | — | — | 1,273,420 | Nov 23, 2020 |
| Cormorant Global Healthcare Master Fund, LP | — | C | 2,845,544 | — | — | 2,845,544 | Nov 23, 2020 |
| Graham G. Walmsley | — | C | 1,400,761 | — | — | 1,400,761 | Nov 23, 2020 |
| RAPPAPORT ANDREW | — | C | 129,833 | — | — | 481,014 | Nov 23, 2020 |
| Myles David C. | Chief Development Officer | C | 12,831 | — | — | 12,831 | Nov 23, 2020 |
| MCCORMICK FRANK | — | C | 152,891 | — | — | 191,113 | Nov 23, 2020 |
| Kushner Peter J. | Chief Scientific Officer | C | 228,761 | — | — | 1,301,513 | Nov 23, 2020 |
| Harmon Cyrus | Chief Technology Officer | C | 122,028 | — | — | 122,028 | Nov 23, 2020 |
| BIOTECHNOLOGY VALUE FUND II LP | — | Purchase | 446,425 | $19.00 | $8,482,075 | 2,523,265 | Nov 19, 2020 |
| Bohen Sean | President and CEO | Option Exercise | 51,649 | $4.82 | $248,948 | 51,649 | Sep 23, 2020 |